1,800
Participants
Start Date
September 30, 2016
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
Aspirin
"Aspirin (acetylsalicylic acid) has a marketing approval for use in the EU and is widely available as an over the counter medicine. However it is not being used within its licensed indication and the aspirin (at any dose in this study) will be treated as an investigational medicinal product (IMP).~Tablets will be provided as enteric-coated 100mg or 300mg tablets for oral use. All patients will receive at least some dose of aspirin but blinding to the actual dose will be achieved by the use of 'dummy' tablets using the same excipients as in the active formulation of the aspirin minus the active ingredient.~The aspirin and dummy tablets should be stored at room temperature below 25⁰C in a dry place."
Sourasky Medical Center, Tel Aviv
Rambam Health Care Campus
OTHER
Rabin Medical Center
OTHER
Soroka University Medical Center
OTHER
Sheba Medical Center
OTHER_GOV
Tel-Aviv Sourasky Medical Center
OTHER_GOV